U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06949137) titled 'Intravenous Infusion of hMSC100 (hUC-MSC) in Postmenopausal Women With Osteoporosis at High Risk of Fracture' on April 22.
Brief Summary: The primary objective of this study is to evaluate the safety and tolerability of human umbilical cord-derived mesenchymal stem cells for injection (hMSC100) in postmenopausal women with osteoporosis who are at high risk of fracture.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Osteoporosis in Post-menopausal Women
Osteoporosis
Intervention:
BIOLOGICAL: Human Umbilical Cord-derived Mesenchymal stem cell
Intravenous infusion of hMSC100 at 20-25 drops per minute
Recruit...